Govt plans to make commonly used drugs available at local retail outlets

This is expected to help people in rural and far-flung areas, where pharmacies are rare

drugs, medicine, pharmaceuticals
Photo: Shutterstock
Sohini Das Mumbai
3 min read Last Updated : Oct 28 2019 | 12:46 AM IST
If you have fever, you need to go to a pharmacy to get even a paracetamol, a common drug for fever and pain. But, the government plans to soon make such drugs available at local retail outlets, with their labelling containing important information — preferred dosage and side effects — in local languages.

This is expected to help people in rural and far-flung areas, where pharmacies are rare. 

“A new schedule is likely to be created under the Drugs and Cosmetics Act for OTC (over-the-counter) drugs so that these commonly used medicines that are not ‘prescription only’ and are relatively safe to use can be governed,” said a senior government official who did not want to be named. 

He added: “There is a need to make such drugs available to more people. This will reduce the cost of treatment.” The official said many people preferred to self-medicate instead of going to a doctor, which is expensive for them.

Paracetamol is an OTC drug. There are no norms at present to regulate these.

Making such essential drugs easily available is important, especially because in India there is less than one doctor per 1,000 people. Also, nearly 74 per cent of doctors in the country cater to a third of the urban population.

The government, however, is cautious to ensure that the regulations are stringent enough to prevent misuse or overuse of these drugs, which might compromise safety of patients.

“There could be multiple categories of OTC drugs depending on its therapeutic value and risk profile,” said the official quoted above.

The policy to govern OTC drugs has been in the works for nearly a year now, said industry sources. Several senior executives of pharmaceutical majors as well as the Organisation of Pharmaceutical Producers of India (OPPI) are providing inputs to the government on the matter.

In its paper, “Shaping India’s OTC Policy 2018”, the OPPI said OTC drugs here are a mix of the following — widely available and mass-advertised brands, drugs outside Schedule H but not mass advertised (referred to as deemed OTC), and also drugs in Schedule H but sold without a prescription to patients upon repeat purchase (after an initial prescription by the doctor), and referred to as OTx products. Deemed OTC drugs (such as common calcium supplements) comprise almost 60 per cent of India’s OTC market, estimated to be about Rs 25,000 crore.


Turning a new leaf
 
The government is coming up with a new schedule for over-the-counter (OTC) drugs under the Drugs and Cosmetics Act
 
Current status
 
  •  Multiple categories, depending on risk factor and therapeutic value
  •  No clear definition
     
Future plans
 
  • Govt plans to govern sale, quality, prices and advertising norms of OTC drugs
  • To increase availability; make these available at retail stores
  • Labelling in local languages, with information on safety, how to use, expiry and common side effects
  • Drug packs could be according to desirable dosages to avoid prolonged use

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :MedicinesparacetamolOTC drugs

Next Story